You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hodgkin's

Showing 1 - 25 of 4,440
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

Not yet recruiting
  • Lymphoma, Non-Hodgkin's, Adult
  • (no location specified)
Aug 4, 2023

Hodgkin Disease Trial in France (Morphological and functional magnetic resonance imaging (MRI), Neuropsychological assessment)

Not yet recruiting
  • Hodgkin Disease
  • Morphological and functional magnetic resonance imaging (MRI)
  • Neuropsychological assessment
  • Arras, France
  • +3 more
Oct 31, 2023

Non-hodgkin Lymphoma Trial (HY004)

Not yet recruiting
  • Non-hodgkin Lymphoma
  • HY004
  • (no location specified)
Aug 21, 2023

Non-Hodgkin Lymphoma Trial in Sohag (real time pcr)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • real time pcr
  • Sohag, Egypt
    Sohag University
Jun 27, 2023

Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

Not yet recruiting
  • Classical Hodgkin Lymphoma
  • Non-Hodgkin Lymphoma
  • GEN3017
  • (no location specified)
Aug 25, 2023

Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • SIRPant-M
  • External-beam radiotherapy (XRT)
  • Duarte, California
  • +2 more
Jul 21, 2023

CD20-positive B-cell Non-Hodgkin's Lymphoma Trial in Beijing (IMM0306)

Recruiting
  • CD20-positive B-cell Non-Hodgkin's Lymphoma
  • Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Apr 6, 2023

Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory, Advanced Solid Tumor Trial (TR115)

Not yet recruiting
  • Non-Hodgkin's Lymphoma, Relapsed
  • +2 more
  • (no location specified)
Dec 6, 2022

Classical Hodgkin Lymphoma Trial in Guangzhou (Zimberelimab 240mg)

Recruiting
  • Classical Hodgkin Lymphoma
  • Zimberelimab 240mg
  • Guangzhou, Guangdong, China
    Department of Medical Oncology, Sun Yat-Sen University Cancer Ce
Jun 15, 2023

Non-Hodgkin's Lymphoma and Hodgkin's Disease

Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    Sep 9, 2022

    Hodgkin Lymphoma Trial in Cologne (Pembrolizumab)

    Not yet recruiting
    • Hodgkin Lymphoma
    • Cologne, Germany
      1st Department of Medicine, Cologne University Hospital
    Sep 19, 2023

    Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

    Active, not recruiting
    • Lymphoma, Non-Hodgkin
    • Stem cell infusion
    • +5 more
    • Saint Louis, Missouri
      Washington University
    Jan 17, 2023

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Living Conditions After Non-Hodgkin's Lymphoma in France

    Not yet recruiting
    • Non-hodgkin's Lymphoma
    • Data collection
    • Questionnaires
    • Dijon, France
      Chu Dijon Bourgogne
    Oct 13, 2022

    Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Low-field magnetic resonance imaging
    • +3 more
    • Erlangen, Bavaria, Germany
      Department of Pediatrics and Adolescent Medicine
    Oct 23, 2023

    B-cell Non Hodgkin Lymphoma Trial in Hanzhou (CB dualCAR-NK19/70)

    Not yet recruiting
    • B-cell Non Hodgkin Lymphoma
    • CB dualCAR-NK19/70
    • Hanzhou, Zhejiang, China
      2nd Affiliated Hospital, School of Medicine, Zhejiang University
    Dec 25, 2022

    Advanced Solid Tumors, B-cell Non-Hodgkin Lymphomas Trial (ATG-031)

    Not yet recruiting
    • Advanced Solid Tumors
    • B-cell Non-Hodgkin Lymphomas
    • (no location specified)
    Aug 31, 2023

    Lymphoma, Non-Hodgkin Trial (JNJ-87801493, JNJ-80948543, JNJ-75348780)

    Not yet recruiting
    • Lymphoma, Non-Hodgkin
    • (no location specified)
    Nov 15, 2023

    Safety Issues, Efficacy, Self Trial in Monterrey (low dose nivolumab in combination with AVD)

    Recruiting
    • Safety Issues
    • Efficacy, Self
    • low dose nivolumab in combination with AVD
    • Monterrey, Nuevo Leon, Mexico
      Hospital Universitario Dr Jose Eleuterio Gonzalez
    Mar 6, 2023

    Classic Hodgkin Lymphoma Trial (Concurrent penpulimab and AVD, Sequential penpulimab and AVD)

    Not yet recruiting
    • Classic Hodgkin Lymphoma
    • Concurrent penpulimab and AVD
    • Sequential penpulimab and AVD
    • (no location specified)
    Jul 10, 2023

    Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma Trial in Isehara, Chuo-ku (tazemetostat)

    Completed
    Has Results
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • Isehara, Kanagawa, Japan
    • +1 more
    Apr 6, 2022

    Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult, Refractory Hodgkin Lymphoma Trial in Boston (Nivolumab, Ipilimumab)

    Recruiting
    • Hodgkin Lymphoma
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Oct 18, 2022

    Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

    Not yet recruiting
    • Non-hodgkin Lymphoma
    • +9 more
    • CD79b-19 CAR T cells
    • +2 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 6, 2023

    Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma Trial in Beijing (JS203 for Injection)

    Not yet recruiting
    • Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
    • JS203 for Injection
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Nov 11, 2022